Spring Research Update Meeting 2025
Our 2025 Spring Research Update Meeting will take place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invite guests to an inspiring agenda of some of the most up to date news of our funded...
Learn more
Cure Parkinson’s Fundraising Heroes: February 2024
February’s fundraising heroes have all taken on long term fundraising events to support our research. An untraditional triathlon Fundraising heroes Phil and Sue created their own triathlon-inspired challenge to raise funds for our research following Phil’s Parkinson’s diagnosis and to mark Sue’s 70th birthday. They…
The Power of HIIT for Parkinson’s
A small pilot study has found that high-intensity interval training – or HIIT – can have positive effects for people with Parkinson’s, both on overall well-being and potentially on brain chemistry.
Latest updates in the field of neurotrophic factors in Parkinson’s
Neurotrophic factors such as GDNF are still being actively investigated as a potential treatment for Parkinson’s, and alternative methods of delivery are currently being explored.
Press Release: Phase 2 clinical trial of dapansutrile for Parkinson’s confirmed
23 February 2024 Cure Parkinson’s, in partnership with Van Andel Institute, is delighted to announce funding for a Phase 2 clinical of dapansutrile, an anti-inflammatory drug, to determine whether it can slow the progression of Parkinson’s. The DAPA-PD trial will evaluate the safety and tolerability…
Phase 2 clinical trial of dapansutrile for Parkinson’s confirmed
Cure Parkinson’s, in partnership with Van Andel Institute, is delighted to announce funding for a Phase 2 clinical of dapansutrile, an anti-inflammatory drug, to determine whether it can slow the progression of Parkinson’s.